Percutaneous absorption of m-xylene vapour in volunteers during pre-steady and steady state

Toxicology Letters

Volumn 153, Issue 2, 2004, Pages 273-282

  Kezic, Sanja ^a   Janmaat, Astrid ^a   Krüse, Jacob ^b   Monster, Aart C ^a   Verberk, Maarten M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Kinetox ^*  (Netherlands)

Author keywords

Deconvolution; Dermal absorption; Organic solvents; Skin permeation models; Vapours; Volunteers

Indexed keywords

META XYLENE;

ADULT; ARTICLE; BLOOD; CONTROLLED STUDY; EXPIRED AIR; FOREARM; HAND; HUMAN; HUMAN EXPERIMENT; INHALATION; MALE; MATHEMATICAL COMPUTING; NORMAL HUMAN; PRIORITY JOURNAL; SKIN ABSORPTION; STEADY STATE; VAPOR;

ADMINISTRATION, INHALATION; ADULT; HUMANS; MALE; MIDDLE AGED; SKIN ABSORPTION; VOLATILIZATION; XYLENES;

EID: 4644335091     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2004.05.006     Document Type: Article

References (34)

1. TSDR (Agency for Toxic Substances and Disease Registry). 1993. Toxicological Profile for Xylenes. Draft for Public Comment. Prepared by Clement International Corporation, under Contract No. 205-88-0608 for ATSDR, Public Health Service, U.S. Department of Health and Human Services.
2. Brooke I., Cocker J., Delic J.I., Payne M., Jones K., Gregg N.C., Dyne D. Dermal uptake of solvents from the vapour phase: an experimental study in humans. Ann. Occup. Hyg. 42:1998;531-540
3. Bunge A.L., Cleek R.L., Vecchia B.E. A new method for estimating dermal absorption from chemical exposure.3. Compared with steady-state methods for prediction and data analysis. Pharm. Res. 12:1995;972-982
4. Chemiekaarten, 1998, 14th ed. Nederlands Instituut voor Arbeidsomstandigheden, NIA, Vereniging van de Nederlandsa Chemische Industrie, VNCI. Samson HD Tjeenk Willing.
5. Cleek R.L., Bunge A.L. A new method for estimating dermal absorption from chemical exposure. 1. General Approach. Pharm. Res. 10:1993;497-506
6. De Nationale MAC-lijst, 2001. Den Haag: Arbeidsinspectie.
7. Drover D.R., Angst M.S., Valle M., Ramaswamy B., Naidu S., Stanski D.R., Verotta D. Input characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteers. Anesthesiology. 97:2002;827-836
8. Frasch H.F. A random walk model of skin permeation. Risk Anal. 22:2002;265-276
9. Guy R.H., Potts R.O. Penetration of industrial chemicals across the skin: a predictive model. Am. J. Ind. Med. 23:1993;711-719
10. Hovorka R., Chappell M.J., Godfrey K.R., Madden F.N., Rouse M.K., Soons P.A. CODE: a deconvolution program implementing a regularization method of deconvolution constrained to non-negative values. Description and pilot evaluation. Biopharm. Drug Dispos. 19:1998;39-53
11. Inoue O., Seiji K., Kawai T., Watanabe T., Jin C., Cai S.X., Chen Z., Qu Q.S., Zhang T., Ikeda M. Excretion of methylhippuric acids in urine of workers exposed to a xylene mixture: comparison among three xylene isomers and toluene. Int. Arch. Occup. Environ. Health. 64:1993;533-539
12. Jones, K., Dick, I., Cocker, J., Roff, M., 2002. Dermal absorption of vapours: comparison of in vivo and in vitro data. In: Proceedings of the International Conference on Occupational & Environmental Exposures of Skin to Chemicals: Science & Policy.
13. Kezic S., Mahieu K., Monster A.C., de Wolff F.A. Dermal absorption of vaporous and liquid 2-methoxyethanol and 2-ethoxyethanol in volunteers. Occup. Environ. Health. 54:1997;38-43
14. Kezic S., Monster A.C., Kruse J., Verberk M.M. Skin absorption of some vaporous solvents in volunteers. Int. Arch. Occup. Environ. Health. 73:2000;415-422
15. Lamson M.J., Sabo J.P., MacGregor T.R., Pav J.W., Rowland L., Hawi A., Cappola M., Robinson P. Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteers. Biopharm. Drug Dispos. 20:1999;285-291
16. Levitt D.G. The use of a physiologically based pharmacokinetic model to evaluate deconvolution measurements of systemic absorption. BMC Clin. Pharmacol. 19:2003;1-21
17. Loizou G.D., Jones K., Akrill P., Dyne D., Cocker J. Estimation of the dermal absorption of m-xylene vapor in humans using breath sampling and physiologically based pharmacokinetic analysis. Toxicol. Sci. 48:1999;170-179
18. Madden F.N., Godfrey K.R., Chappell M.J., Hovorka R., Bates R.A. A comparison of six deconvolution techniques. J. Pharmacokinet. Biopharm. 24:1996;283-299
19. McDougal J.N., Jurgens-Whitehead J.L. Short-Term dermal absorption and penetration of chemicals from aqueous solutions: theory and experiment. Risk Anal. 21:2001;719-726
20. Moss G.P., Dearden J.C., Patel H., Cronin M.T. Quantitative structure-permeability relationships (QSPRs) for percutaneous absorption. Toxicol. In Vitro. 16:2002;299-317
21. Opdam J.J.G. The respiratory uptake in inhalation experiments. Br. J. Ind. Med. 46:1989;145-156
22. Opdam J.J.G. Linear system dynamics in toxicokinetic studies. Ann. Occup. Hyg. 35:1991;633-649
23. Patel H., Ten Berge W., Cronin M.T.D. Quantitative structur-activity relationship for the prediction of skin permeation of exogenous chemicals. Chemosphere. 48:2002;603-613
24. Poet T.S., Thrall K.D., Corley R.A., Hui X., Edwards J.A., Weitz K.K., Maibach H.I., Wester R.C. Utility of real time breath analysis and physiologically based pharmacokinetic modeling to determine the percutaneous absorption of methyl chloroform in rats and humans. Toxicol. Sci. 54:2000;42-51
25. Potts R.O., Guy R.H. Predicting skin permeability. Pharm. Res. 9:1992;663-669
26. Riihimaki V., Pfaffli P. Percutaneous absorption of solvent vapours in man. Scand. J. Work Environ. Health. 4:1978;73-85
27. Ten Berge W.F., 2003. http://home.planet.nl/∼wtberge/skinperm.html.
28. U.S. EPA., 2000. EPA Database Kow win v.1.66. Environmental Protection Agency, Washington, DC.
29. Vaughan D.P., Dennis M. Mathematical basis of the 'point-area' deconvolution method for determining in vivo input functions. J. Pharm. Sci. 67:1978;663-667
30. Veng-Pedersen P., Modi N.B. An algorithm for constrained deconvolution based on reparameterization. J. Pharm. Sci. 81:1992;175-180
31. Verotta D. Comments on two recent deconvolution methods. J. Pharmacokinet. Biopharm. 18:1990;483-489. discussion 489-499
32. Wilschut A., Ten W.F., Robinson P.J., McKone T.E. Estimating skin permeation. The validation of five mathematical skin permeation models. Chemosphere. 30:1995a;1275-1296
33. Wilschut, A., Ten Berge, W.F., 1995b. Two mathematical skin permeation models for vapours. In: Brain, K.R., James, V.J., Walters, K.A. (Eds.), Prediction of Percutaneous Penetration, vol. 4a. 3M Medica, La Grande Motte, pp. 182-184.
34. Yu Z., Schwartz J.B., Sugita E.T., Foehl H.C. Five modified numerical deconvolution methods for biopharmaceutics and pharmacokinetics studies. Biopharm. Drug Dispos. 17:1996;521-540